BioVie Inc.
BIVI
$1.66
$0.074.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.29M | 2.38M | 1.59M | 2.53M | 2.07M |
| Depreciation & Amortization | 57.30K | 57.30K | 57.30K | 57.30K | 57.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.28M | 3.66M | 2.99M | 7.29M | 4.12M |
| Operating Income | -5.28M | -3.66M | -2.99M | -7.29M | -4.12M |
| Income Before Tax | -5.09M | -3.49M | -2.79M | -7.11M | -4.15M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.09M | -3.49M | -2.79M | -7.11M | -4.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.09M | -3.49M | -2.79M | -7.11M | -4.15M |
| EBIT | -5.28M | -3.66M | -2.99M | -7.29M | -4.12M |
| EBITDA | -5.23M | -3.61M | -2.93M | -7.24M | -4.06M |
| EPS Basic | -0.98 | -1.88 | -1.51 | -4.55 | -7.00 |
| Normalized Basic EPS | -0.61 | -1.17 | -0.94 | -2.83 | -4.06 |
| EPS Diluted | -0.98 | -1.88 | -1.51 | -4.60 | -7.00 |
| Normalized Diluted EPS | -0.61 | -1.17 | -0.94 | -2.83 | -4.06 |
| Average Basic Shares Outstanding | 5.21M | 1.86M | 1.85M | 1.57M | 639.80K |
| Average Diluted Shares Outstanding | 5.21M | 1.86M | 1.85M | 1.57M | 639.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |